Ver­tex is re­or­ga­niz­ing and con­sol­i­dat­ing R&D, shut­ter­ing a site in Cana­da

Ver­tex has pulled out the ax in a move to chop down the size of its R&D op­er­a­tion.

The big biotech not­ed in its 10-K that the com­pa­ny de­cid­ed last month to shut­ter a re­search site in Cana­da while “con­sol­i­dat­ing” R&D in three lo­ca­tions scat­tered across the coun­try. And com­pa­ny sources tell me that there have been a num­ber of re­cent cuts as well in the home­town R&D group in Boston stretch­ing back over the past year.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER